More Than 6,000 People Infected With Ebola in Congo, Government Figures Show

Home / Blog Details

user Admin_Adham
31st Aug, 2026 12:00 AM
Test

More Than 6,000 People Infected With Ebola in Congo, Government Figures Show

DAKAR, Aug 31 (Reuters) - The number of confirmed Ebola ⁠cases in the Democratic Republic of Congo has ⁠passed the 6,000 mark, government data ⁠showed on Monday.

The ‌epidemic has become the largest in the central African country's history, surpassing the previous worst outbreak that ‌lasted from 2018 to 2020.

It ​is caused ‌by the ‌Bundibugyo strain of Ebola, which has no approved ⁠vaccines or treatments.

The ‌number of ⁠people with ​confirmed infections has ‌risen to 6,041, and 2,911 of them have died, the communication ministry ​said on X.

Article Key Points
  • DRC Ebola cases >6,000; 2,911 deaths reported.
  • Largest Ebola outbreak in DRC history; exceeds 2018-2020 epidemic.
  • Causative strain = Bundibugyo Ebola virus.
  • No approved vaccines or treatments for Bundibugyo strain.
  • Response teams active in 6 provinces; focus on Ituri, North Kivu, Haut-Uele.
Dive Deeper
What predicts mortality in Bundibugyo Ebola infection?
How is Bundibugyo Ebola diagnosed rapidly?
Which infection-control measures limit Ebola spread?

Response ‌teams ‌are working in six provinces affected ‌by the ​outbreak, with a particular focus on Ituri, North Kivu and ⁠Haut-Uele, it added.

SUGGESTED FOR YOU

(Reporting by Anait ‌Miridzhanian; Editing by Alison Williams ​and Andrew Heavens)

Dive Deeper
Reuters Health Information © 2026 Reuters Ltd.

Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Commonly Asked by HCPs
Q: How do Ebola vaccine and treatment options differ by viral strain?
A: Available vaccines and therapeutics are strain-specific or have evidence strongest for certain Ebola species, so clinical and public health strategies depend on the circulating virus. Research typically focuses on cross-protection, outbreak preparedness, and whether existing countermeasures apply across Ebola strains.
Read full answer
Q: How is Ebola virus disease diagnosed and confirmed in suspected cases?
A: Diagnosis of Ebola virus disease relies on clinical suspicion plus laboratory confirmation, typically using RT-PCR on appropriate specimens. Clinicians also consider exposure history, compatible symptoms, differential diagnoses such as malaria or other hemorrhagic fevers, and rapid isolation while testing is underway.
Read full answer
Q: What supportive care improves survival in Ebola virus disease?
A: Supportive care is the main determinant of survival in Ebola virus disease, with aggressive management of dehydration, shock, bleeding risk, renal dysfunction, and secondary infections. Outcomes improve when care is started early and delivered in facilities capable of close monitoring and rapid escalation.
Read full answer
Q: How are patients with Ebola virus disease managed in resource-limited settings?
A: Management in resource-limited settings emphasizes early recognition, isolation, fluid and electrolyte replacement, hemodynamic support, symptom control, and monitoring for complications. Access to laboratory testing, transfusion support, oxygen, and critical care resources can substantially influence outcomes.
Read full answer
Q: What infection control measures are recommended for Ebola outbreak containment?
A: Outbreak containment centers on immediate isolation, PPE use, contact tracing, safe burial practices, and strict decontamination procedures. Public health response also includes surveillance, community engagement, and rapid identification of contacts to interrupt person-to-person transmission.
Read full answer


Share This Article

Comments

Leave a comment

Recent Posts

Cephalosporin Generations Show Similar Outcomes in Pyelonephritis
Use of Biologics Tied to Lower Hospitalisation Risk in IBD
Health Officials Race to Trace Source Of Nigeria's Ebola Infection

Blog categories

Shopping Cart

Loading...